JAM Fund, Unbound, Lux Capital, Northstar, Social Capital, Novastar Ventures & TO Ventures’ investment in mPharma’s operations in Nigeria, Ghana and Zimbabwe

Lead party: JAM Fund, LLC (investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Gabon, Ethiopia, Uganda, Zimbabwe, Kenya, Rwanda, Malawi, Ghana, Zambia, Nigeria Transaction type: Investment, Debt Financing · Asset class: Venture Capital · Strategy:…


Lead party: JAM Fund, LLC (investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Gabon, Ethiopia, Uganda, Zimbabwe, Kenya, Rwanda, Malawi, Ghana, Zambia, Nigeria

Transaction type: Investment, Debt Financing · Asset class: Venture Capital · Strategy: Venture Debt, Venture Equity · Instrument: Equity, Debt · Round: Series C+ · Deal amount: US$35m · Fund: Novastar Ventures Africa Fund II

Investors/buyers: JAM Fund, LLC, Unbound Ventures, Lux Capital, Northstar, Social Capital, Novastar Ventures Limited, TO Ventures

Legal advisers: not identified in the source record.

Source: announced 2 January 2022. Original announcement: techcrunch.com.